analyst day focus sever area includ core lab trend
expand access consumer digit capabl capit deploy
reimburs head wind acceler trend around
access big opportun on-going cost initi help provid
off-set continu like long-term fundament view larg
independ best posit maintain hold cut pt
ep tie modestli lower multipl new estim
diagnost lab busi still plenti like despit hand
continu like lab busi given attract posit
jump point major healthcar decis make increas
pressur pama grow demand low cost high qualiti care
view scale independ provid best posit given rel low
medicar exposur broad test capabl signific cost advantag
addit market remain highli fragment expect grow
challeng smaller less sophist provid mount would expect
continu robust capit deploy opportun rais expect
revenu growth contribut vs prior
horizon anthem ga highest level patient access
decad new access serv attract growth tailwind
forese futur compani size opportun
compani strong visibl short-term account repres
opportun almost half loyalist send
busi outsid remaind mix split
amongst lab account reach sinc june
averag touch addit see addit
medium term account revenu potenti potenti long
hospit oper environ grow challeng hospit
lab servic anoth attract area think growth like
remain strong market ripe opportun hospit lab
typic less effici expens oper thinner margin
addit expect anoth wave increment pama reimburs
pressur think mani larg unawar drive
examin lab strategi mani system addit opportun
tr target
adjust non-control interest equiti
earn jv
oper effici digit capabl on-going reimburs head wind focu
oper efficiency/cost reduct remain acut compani target save
annual go forward basi increas digit effort streamlining/
best practic quest identifi near term cost save increas digit
pre-registr expect bolster digit capabl allow increas eas
data transfer reduc staf need improv product view elimin paper
requisit particularli attract area opportun given cost advantag
significantli lower instanc miss inform prevent bill compat
new pre-author initi aim improv trend around patient concess patient
respons increas encourag new pre-author initi view abil
receiv payment prior test servic key driver reduc denial long term
consum experi focu maxim consum experi remain key
object compani continu expand site care digit initi across
number area focu conveni remain high look meet consum
alreadi safeway privat nr partnership
expand access at-hom specimen test addit digital/mobil capabl
continu reduc oper friction improv patient experi myquest mobil
app provid access on-line schedul test result patient histori e-check
patient queue access reduc patient wait time optim phlebotomist resourc patient
increasingli spend money demand healthcar dollar expect
patient satisfaction/conveni remain key area invest
data king popul health valu base model gain traction data grow
increasingli critic predict model risk share arrang compani continu
leverag databas enhanc popul health capabl earli id manag
program esrd diabet partnership research organ nih cdc
addit think recent launch quest clinic trial connect carri promis includ
improv patient recruit virtual monitor capabl clinic trial
firmli intact guidanc cut disappoint near-term challeng especi patient
concess bear watch continu like core underpin diagnost lab space
view well posit remain upbeat longer term fundament addit
compani gener strong free cash flow expect robust trend continu potenti
acceler increment pama pressur send anoth wave provid toward exit
cut ep estim
reflect updat guidanc lower jump point estim
also cut price target reflect modestli lower multipl new estim
maintain hold rate
page
servic
revenu
revenu
amort intang
equiti earn jv
revenu
equiti earn jv net tax
page
base teterboro nj lead provid diagnost test inform
relat servic compani offer patient physician access diagnost laboratori
servic nation network region laboratori patient servic center
addit rapid respons laboratori compani also offer esoter test includ gene-
base test substanc abus test anatom patholog servic test clinic trial
clinic lab remain integr part healthcar deliveri model diagnost test
critic compon treatment decis process uncertainti around reimburs increas
applaud recent step manag drive sharehold valu reimburs bear
watch volum growth remain key
valuat risk
price target base trade cash ep in-lin
current multipl view appropri risk rate price target upsid
includ acceler volum growth improv price potenti accret downsid
risk includ deceler volum increas denial/pati concess stronger anticip
compani mention note
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
